Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  MOTS-c: The Tiny Mitochondrial Peptide With Big Research Buzz

MOTS-c: The Tiny Mitochondrial Peptide With Big Research Buzz

Jun 11, 2026 4 min Metabolic
TL;DR
MOTS-c is a short peptide encoded inside mitochondrial DNA. Early research in animals and cells suggests it may support insulin sensitivity, reduce obesity, fight inflammation, and even slow certain cancers. Human clinical data is still limited, so everything here is research-stage only.

What Exactly Is MOTS-c?

Think of your mitochondria as tiny power stations inside every cell. Scientists used to believe mitochondria just made energy. Now we know they also send messages — chemical signals that tell the rest of the cell what to do.

MOTS-c (short for Mitochondrial Open Reading Frame of the 12S rRNA-c) is one of those messages. It is a peptide — basically a very short protein — made of just 16 amino acids. It is encoded not by your regular DNA but by the DNA sitting inside your mitochondria.[4]

What makes it unusual is what it does next: under metabolic stress, MOTS-c travels from the mitochondria all the way to the nucleus — the control room of the cell — and directly influences which genes get switched on or off.[3] That kind of cross-organelle communication was not thought possible before its discovery.

Why Do Researchers Care About It?

There are a few clues that MOTS-c matters for health:

  • It declines with age. Blood levels of MOTS-c drop as people get older, which has researchers wondering whether that decline contributes to age-related disease.[1]
  • Exercise raises it. Physical activity appears to increase MOTS-c levels, which is one reason scientists sometimes call it an exercise mimetic — a compound that copies some effects of working out.[6]
  • It targets skeletal muscle. The peptide seems especially active in muscle tissue, which is the body's main site for burning blood sugar.[4]

What Does the Research Actually Show?

Metabolism and Insulin Resistance

The landmark 2015 study published in Cell Metabolism is where MOTS-c first made headlines. Researchers injected the peptide into mice and found it prevented age-related and high-fat-diet-induced insulin resistance. It also reduced diet-induced obesity. The mechanism involves blocking a part of the folate cycle, which triggers a well-known metabolic sensor called AMPK — essentially flipping a switch that tells cells to burn fuel more efficiently.[4]

Later reviews confirmed that MOTS-c activates AMPK signaling and influences genes like GLUT4 (which moves sugar into muscle cells) and STAT3, which is tied to inflammation and immune response.[2]

Aging and Longevity

Because MOTS-c levels fall with age and the peptide can travel to the nucleus to regulate gene expression, researchers at USC and other institutions have framed it as a potential anti-aging signal. The idea is that mitochondria and nuclear DNA need to stay in sync — MOTS-c may be one messenger that keeps that conversation going.[3] Studies suggest it may help with cardiovascular health and systemic inflammation as well.[1]

Pulmonary Fibrosis

Pulmonary fibrosis is a scarring disease of the lungs with few effective treatments. A 2023 review noted that MOTS-c's effects on oxidative stress, mitochondrial function, and inflammation make it a candidate worth investigating as a therapeutic target for this condition — though human trials have not yet been conducted.[6]

Cancer Research

A 2024 study in Advanced Science found that MOTS-c levels were lower in both blood and tumor tissue from ovarian cancer patients with worse outcomes. In cell and animal models, adding MOTS-c slowed cancer cell growth, blocked migration, and triggered cell death — without apparent toxicity to healthy tissue.[5] This is very early-stage research, but it points to an intriguing anti-tumor mechanism.

Where Does the Evidence Stand?

Most of what we know comes from animal studies and cell experiments. Human data is still sparse. Researchers are optimistic, but no approved clinical application exists yet.[1] MOTS-c is currently studied as a research peptide only, and none of this constitutes medical advice.

Interested in the Dosage Data?

If you are a researcher or curious reader looking at how MOTS-c has been dosed in preclinical studies, our MOTS-c dosage chart compiles the published figures in one place. You can also use our calculator to explore weight-based conversions used in research protocols. Always consult a qualified professional before any experimental use.

Sources

  1. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. — Frontiers in endocrinology, 2023. PMID 36761202.
  2. MOTS-c Functionally Prevents Metabolic Disorders. — Metabolites, 2023. PMID 36677050.
  3. MOTS-c: A Mitochondrial-Encoded Regulator of the Nucleus. — BioEssays : news and reviews in molecular, cellular and developmental biology, 2019. PMID 31378979.
  4. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. — Cell metabolism, 2015. PMID 25738459.
  5. Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination. — Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. PMID 39321430.
  6. MOTS-c: A potential anti-pulmonary fibrosis factor derived by mitochondria. — Mitochondrion, 2023. PMID 37307934.
See the dosage chart — MOTS-c
A mitochondrial-derived peptide studied for metabolic regulation.
MOTS-c

FAQ

What is MOTS-c made of?
MOTS-c is a peptide — a short chain of amino acids — only 16 amino acids long. What makes it unique is that it is encoded by mitochondrial DNA, not the DNA in your cell's nucleus. It was first formally identified and described in a landmark 2015 paper published in Cell Metabolism.[4]
Does MOTS-c really decrease as we age?
Research suggests yes. Studies have found that circulating MOTS-c levels in the blood drop with advancing age. Scientists hypothesize that this age-related decline may contribute to metabolic problems like insulin resistance and increased inflammation, though cause-and-effect in humans has not been firmly established yet.[1]
Is MOTS-c the same as an exercise pill?
Not exactly, but some researchers describe it as an 'exercise mimetic' because physical activity raises MOTS-c levels and the peptide appears to activate some of the same metabolic pathways — particularly AMPK — that exercise triggers. Studies also link it to improved muscle function and reduced obesity in animal models.[2][6]
Is MOTS-c approved as a drug or treatment?
No. As of the latest published literature, MOTS-c has no approved clinical application. The research is promising but mostly preclinical — meaning it has been tested in cells and animals, not in large-scale human trials. It is currently a research-use-only compound, and this article is educational, not medical advice.[1]
For research and educational use only. Not medical advice.